Status: current, Defined. Date: 30-Sep 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2700891000168112 | Tranexamic (AFT) (tranexamic acid 500 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2700901000168111 | Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Is a | Tranexamic (AFT) | true | Inferred relationship | Some | ||
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Is a | tranexamic acid 500 mg/5 mL injection, ampoule | true | Inferred relationship | Some | ||
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 698598027 | |
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | has intended active ingredient | tranexamic acid | true | Inferred relationship | Some | 698598026 | |
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | has Australian BoSS | tranexamic acid | true | Inferred relationship | Some | 698598026 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | has TPUU | True | Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Tranexamic (AFT) 500 mg/5 mL injection, 10 x 5 mL ampoules | has TPUU | True | Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Tranexamic (AFT) 500 mg/5 mL injection, 5 x 5 mL ampoules | has TPUU | True | Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Tranexamic (AFT) 500 mg/5 mL injection, 5 x 5 mL ampoules | has TPUU | True | Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | has TPUU | True | Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Tranexamic (AFT) 500 mg/5 mL injection, 10 x 5 mL ampoules | has TPUU | True | Tranexamic (AFT) 500 mg/5 mL injection, 5 mL ampoule | Inferred relationship | Some | 1 |
Reference Sets
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR